4 results loaded, newest first. End of these results.
News 2026-09-29 12:31 UTC
FibroBiologics, Inc. was granted European Patent No. 3568465 for methods to enhance fibroblast therapeutic activity using platelet rich plasma and cytokines, with claims including angiogenesis and spinal disc regeneration.Material DetailsContext by AI AnalystThis is an early-stage IP expansion supp…
News 2026-09-29 12:31 UTC
FibroBiologics (FBLG) announced it has been granted a European patent covering methods of enhancing fibroblast therapeutic activity.
News 2026-09-29 12:30 UTC
Newly Granted Patent Covers Methods of Augmenting the Regenerative Efficacy of Fibroblasts Using Platelet Rich Plasma and Cytokines, with Claims Directed to Angiogenesis and Spinal Disc RegenerationHOUSTON, Sept. 29, 2026 // -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics" or the…
News 2026-08-05 12:30 UTC
FibroBiologics gets patent for cartilage regeneration